Cafepharma Today

January 3 2025 - Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Lilly asks to join GLP-1 compounding lawsuit
Use of diabetes and anti-obesity drugs surges nationwide
How pharma was instrumental in President Jimmy Carter’s global health efforts
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co.
Seeking Alpha
Tuesday, September 23, 2008 - 12:23pm
tags:
FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
PR NewsWire
Tuesday, September 23, 2008 - 12:23pm
tags:
Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
PR NewsWire
Tuesday, September 23, 2008 - 12:21pm
tags:
Urodynamix and Pfizer Inc. Collaborate on Urologist Program
Trading Markets
Tuesday, September 23, 2008 - 12:20pm
tags:
Teva introduces first generic version of Cardene
Globes, Israel
Tuesday, September 23, 2008 - 12:19pm
tags:
Sun Pharmaceutical Industries gets USFDA approval for ANDA
Business Standard, India
Tuesday, September 23, 2008 - 12:18pm
tags:
Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
Trading Markets
Tuesday, September 23, 2008 - 12:17pm
tags:
Biotech Names With Big Potential
Seeking Alpha
Tuesday, September 23, 2008 - 12:16pm
tags:
Merck Serono Announces One-Month Results of Pharmacogenomics Study PREDICT at 47th Annual Meeting of the European Society for Paediatric Endocrinology
PR NewsWire
Tuesday, September 23, 2008 - 12:14pm
tags:
AstraZeneca sees developed markets stalling
Guardian, UK
Tuesday, September 23, 2008 - 7:33am
tags:
NicOx reaches deal With Pfizer's Capsugel for Commercial Manufacture of Naproxcinod Oral Capsules
RTT News
Tuesday, September 23, 2008 - 7:32am
tags:
The Medicines Company: Good for what ails you
Yahoo/SmallCapInvestor.com
Tuesday, September 23, 2008 - 7:30am
tags:
Teva Pharmaceutical to enter Japan via joint venture
Marketwatch
Tuesday, September 23, 2008 - 7:29am
tags:
Key PDL patents under fire
Bizjournals.com
Tuesday, September 23, 2008 - 7:28am
tags:
BMY Ups the Ante on ImClone
Seeking Alpha
Tuesday, September 23, 2008 - 7:24am
tags:
Credit Suisse upgrades Novartis, downgrades Sanofi-Aventis
Marketwatch
Tuesday, September 23, 2008 - 7:24am
tags:
Bristol-Myers Squibb, ImClone Systems report positive long-term Erbitux study data
Yahoo/AP
Monday, September 22, 2008 - 5:09pm
tags:
Pfizer retooling, pushing emerging market sales
Yahoo/AP
Monday, September 22, 2008 - 5:08pm
tags:
Ouch, That's Gotta Hurt! (Effexor vs. Acupuncture)
Motley Fool
Monday, September 22, 2008 - 4:33pm
tags:
CytRx closes on Innovive
Bizjournals.com
Monday, September 22, 2008 - 4:29pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Recipes Blogging: Kebab-e-Koobideh
In the Pipeline
Recipe Blogging: Varieties of Pickles
In the Pipeline
Targeted Cancer Drugs, Succeeding and Failing
In the Pipeline
Drugs Inside Cells - A Bit of Light
In the Pipeline
HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline

Latest Jobs

Vascular Consultant - 1719
League City, Texas, United States
FloodGate Medical
Clinical Specialist - $120K-$130K - Cardiovascular Space (Richmond, Charlottesville, Roanoke)
Roanoke, Virginia, United States
The Hoffman Group - Executive Recruiters
Associate Med device sales rep - diabetes
White Plains, New York, United States
DAVID BAGGA COMPANY
Specialty Account Manager - IVIG
Boston, Massachusetts, United States
CSI Pharmacy
Sales Representative, Iron Specialist, Women's Health - San Bernardino, CA
San Bernardino County, California, United States
RxSalesPros
Account Executive- Columbus
Columbus, Ohio, United States
CCS
Sales Representative, Iron Specialist, Women's Health - Sacramento, CA
Sacramento, California, United States
RxSalesPros
Territory Manager/ Pharmaceutical Sales Representative – Women’s Healthcare
Katy, Texas, United States
ImpactBio
Specialty Account Manager - IVIG
Charlotte, North Carolina, United States
CSI Pharmacy
Ophthalmology Pharmaceutical Sales Representative - Austin North Territory
Austin, Texas, United States
EVERSANA
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information